Bibliography: library/10665-350214

The reference for library/10665-350214 (who-iris) and any references extracted from it. library · All references.

Export these 64 references: BibTeX · CSL-JSON · RIS · Dublin Core XML · Dublin Core / BIBO JSON-LD

✍ + Add reference (standalone node)

Build a standalone folio-reference/v1 node at references/reference.jsonld from fields or pasted BibTeX / CSL-JSON.



· ✍ Create standalone node on GitHub · Download .jsonld · Download .csl.json ·

64 shown

  1. World Health Organization (2021). Comprehensive package of care for infants and young children exposed to HIV: policy brief. World Health Organization.
    10665-350214 · catalogue · link · repository record · ISBN 9789240040236 (electronic version) · source: catalogue/records/10665-350214.dc.json · held: library/10665-350214
    export: BibTeX · RIS · CSL-JSON · DC XML
  2. UNAIDS epidemiological estimates [online database]. Geneva: UNAIDS; 2021 (https://aidsinfo.unaids.org, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.1.json
  3. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: World Health Organization; 2021 update (https://apps.who.int/iris/handle/10665/342899, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.2.json
  4. Shapiro R, Lockman S. Mortality among HIV-exposed infants: the first and final frontier. Clin Infect Dis. 2010;50:445–7.
    · extracted · source: references/10665-350214.sec-070.3.json
  5. Xiao PL, Zhou YB, Chen Y, Yang MX, Song XX, Shi Y et al. Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies. BMC Pregnancy Childbirth. 2015;15:246.
    · extracted · source: references/10665-350214.sec-070.4.json
  6. Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and neurodevelopment of HIV-exposed uninfected children: a conceptual framework. Curr HIV/AIDS Rep. 2019;16:501–13.
    · extracted · source: references/10665-350214.sec-070.5.json
  7. Brahmbhatt H, Kigozi G, Wabwire-Mangen F, Serwadda D, Lutalo T, Nalugoda F et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immune Defic Syndr. 2006;41:504–8.
    · extracted · source: references/10665-350214.sec-070.6.json
  8. Marinda E, Humphrey JH, Iliff PJ, Mutasa K, Nathoo KJ, Piwoz EG et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26:519–26.
    · extracted · source: references/10665-350214.sec-070.7.json
  9. Kuhn L, Sinkala M, Semrau K, Kankasa C, Kasonde P, Mwiya M et al. Elevations in mortality associated with weaning persists into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis. 2010;50:437–44.
    · extracted · source: references/10665-350214.sec-070.8.json
  10. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236–43.
    · extracted · source: references/10665-350214.sec-070.9.json
  11. Sugandhi N, Rodrigues J, Kim M, Ahmed S, Amzel A, Tolle M et al. HIV-exposed infants: rethinking care for a lifelong condition. AIDS. 2013;27(Suppl. 2):S187–95.
    · extracted · source: references/10665-350214.sec-070.10.json
  12. Slogrove AL, Goetghebuer T, Cotton MF, Singer J, Bettinger JA. Pattern of infectious morbidity in HIV-exposed uninfected infants and children. Front Immunol. 2016;7:164.
    · extracted · source: references/10665-350214.sec-070.11.json
  13. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the women and infants transmission study. J Infect Dis. 2006;194:1089–97.
    · extracted · source: references/10665-350214.sec-070.12.json
  14. Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787–97.
    · extracted · source: references/10665-350214.sec-070.13.json
  15. Kiragu K, Collins L, Von Zinkernagel D, Mushavi A. Integrating preventing mother-to-child transmission into maternal, newborn, and child health and related services: experiences from the Global Plan priority countries. J Acquir Immune Defic Syndr. 2017; 75:S36–42.
    · extracted · source: references/10665-350214.sec-070.14.json
  16. Smith BL, Zizzo S, Amzel A, Wiant S, Pezzulo MC, Konopka S et al. Integration of neonatal and child health interventions with pediatric HIV interventions in global health. Int J MCH AIDS. 2018;7:192–206.
    · extracted · source: references/10665-350214.sec-070.15.json
  17. Kerber KJ, de Graft-Johnson JE, Bhutta ZA, Okong P, Starrs A, Lawn JE. Continuum of care for maternal, newborn, and child health: from slogan to service delivery. Lancet. 2007;370:1358–69.
    · extracted · source: references/10665-350214.sec-070.16.json
  18. Mazia G, Narayanan I, Warren C, Mahdi M, Chibuye P, Walligo A et al. Integrating quality postnatal care into PMTCT in Swaziland. Glob Public Health. 2009;4:253–70.
    · extracted · source: references/10665-350214.sec-070.17.json
  19. Tomlinson M, Doherty T, Ijumba P, Jackson D, Lawn J, Persson LÅ et al. Goodstart: a cluster randomised effectiveness trial of an integrated, community-based package for maternal and newborn care, with prevention of mother-to-child transmission of HIV in a South African township. Trop Med Int Health. 2014;19:256–66.
    · extracted · source: references/10665-350214.sec-070.18.json
  20. Wang PC, Mwango A, Moberley S, Brockman BJ, Connor AL, Kalesha-Masumbu P et al. A cluster randomised trial on the impact of integrating early infant HIV diagnosis with the Expanded Programme on Immunization on immunization and HIV testing rates in rural health facilities in southern Zambia. PloS One. 2015;10:e0141455.
    · extracted · source: references/10665-350214.sec-070.19.json
  21. Patel MR, Yotebieng M, Behets F, Vanden Driessche K, Nana A, Van Rie A. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level. Int J Tuberc Lung Dis. 2013;17:1206–11.
    · extracted · source: references/10665-350214.sec-070.20.json
  22. Goodson JL, Finkbeiner T, Davis N, Lyimo D, Rwebembera A, Swartzendruber AL et al. Evaluation of using routine infant immunization visits to identify and follow-up HIV-exposed infants and their mothers in Tanzania. J Acquir Immune Defic Syndr. 2013;63:e9–15.
    · extracted · source: references/10665-350214.sec-070.21.json
  23. Cohn J, Whitehouse K, Tuttle J, Lueck K, Tran T. Paediatric HIV testing beyond the context of prevention of mother-to-child transmission: a systematic review and meta-analysis. Lancet HIV. 2016;3:e473–81.
    · extracted · source: references/10665-350214.sec-070.22.json
  24. Myer L, Phillips T, Manuelli V, McIntyre J, Bekker LG, Abrams EJ. Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2015;69:e57–65.
    · extracted · source: references/10665-350214.sec-070.23.json
  25. Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case–control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis. 2010;50:585–96.
    · extracted · source: references/10665-350214.sec-070.24.json
  26. Mandelbrot L, Tubiana R, le Chenadec J, Dollfus C, Faye A, Pannier E et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;61:1715–25.
    · extracted · source: references/10665-350214.sec-070.25.json
  27. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/250796, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.26.json
  28. Esopo K, Derby L, Haushofer J. Interventions to improve adherence to antenatal and postnatal care regimens among pregnant women in sub-Saharan Africa: a systematic review. BMC Pregnancy Childbirth 2020;20:316.
    · extracted · source: references/10665-350214.sec-070.27.json
  29. Metcalfe R, Adegoke A. Strategies to increase facility-based skilled birth attendance in South Asia: a literature review. Int Health. 2013;5:96–105.
    · extracted · source: references/10665-350214.sec-070.28.json
  30. WHO consolidated guidelines on HIV testing services, 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/336323).
    · extracted · link · source: references/10665-350214.sec-070.29.json
  31. Le Roux S, Myer L, Vojnov L. Clinical and operational impact of point-of-care compared to laboratory-based nucleic acid testing for routine HIV viral load monitoring: a systematic review and meta-analysis. In preparation.
    · extracted · source: references/10665-350214.sec-070.30.json
  32. Drain PK, Dorward J, Violette LR, Quame-Amaglo J, Thomas KK, Samsunder N et al. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (stream): findings from an open-label, non inferiority, randomised controlled trial. Lancet HIV. 2020;7:e229–37.
    · extracted · source: references/10665-350214.sec-070.31.json
  33. Boeke CE, Joseph J, Atem C, Banda C, Coulibaly KD, Doi N et al. Evaluation of near point-of-care viral load implementation in public health facilities across seven countries in sub-Saharan Africa. J Int AIDS Soc. 2021;24:e25663.
    · extracted · source: references/10665-350214.sec-070.32.json
  34. Bourne DE, Thompson M, Brody LL, Cotton M, Draper B, Laubscher R et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101–6.
    · extracted · source: references/10665-350214.sec-070.33.json
  35. Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.
    · extracted · source: references/10665-350214.sec-070.34.json
  36. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet. 2007;370:68–80.
    · extracted · source: references/10665-350214.sec-070.35.json
  37. Marston M, Becquet R, Zaba B, Moutleon LH, Gray G, Coovadia H et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol. 2011;40:385–96.
    · extracted · source: references/10665-350214.sec-070.36.json
  38. Moodley D, Bobat RA, Coutsoudis A, Coovadia HM. Predicting perinatal human immunodeficiency virus infection by antibody patterns. Pediatr Infect Dis J. 1995;14: 850–2.
    · extracted · source: references/10665-350214.sec-070.37.json
  39. Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hillyer GV, Diaz C. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J. 1995;14:382–7.
    · extracted · source: references/10665-350214.sec-070.38.json
  40. Global AIDS Monitoring 2020. Geneva: UNAIDS; 2020 (https://aidsinfo.unaids.org, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.39.json
  41. Luo R, Boeras D, Vojnov L. Systematic review on the clinical impact of point-of-care early infant diagnosis for HIV. In preparation.
    · extracted · source: references/10665-350214.sec-070.40.json
  42. Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340190, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.41.json · held: library/10665-340190
  43. Bianchi F, Cohn J, Sacks E, Bailey R, Lemaire JF, Machekano R et al. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries. Lancet HIV. 2019;6:e373–81.
    · extracted · source: references/10665-350214.sec-070.42.json
  44. Guideline – updates on HIV and infant feeding: the duration of breastfeeding, and support from health services to improve feeding practices among mothers living with HIV. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/handle/10665/246260, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.43.json
  45. Beste S, Essajee S, Siberry G, Hannaford A, Dara J, Sugandhi N et al. Optimal antiretroviral prophylaxis in infants at high risk of acquiring HIV: a systematic review. Pediatr Infect Dis J. 2018;37:169–75.
    · extracted · source: references/10665-350214.sec-070.44.json
  46. HIV diagnosis and ARV use in HIV-exposed infants: a programmatic update. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/273155, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.45.json · held: library/10665-273155
  47. Guidelines on co-trimoxazole prophylaxis for HIV related infections among children, adolescents and adults: recommendations for a public health approach. Geneva: World Health Organization; 2006 (https://apps.who.int/iris/handle/10665/43557, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.46.json
  48. Walker AS, Mulenga V, Ford D, Kabamba D, Sinyinza F, Kankasa C et al. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. Clin Infect Dis. 2007;44:1361–7.
    · extracted · source: references/10665-350214.sec-070.47.json
  49. Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, Sinyinza F et al. Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children. AIDS. 2007;21:77–84.
    · extracted · source: references/10665-350214.sec-070.48.json
  50. Campbell JD, Moore D, Degerman R, Kaharuza F, Were W, Muramuzi E et al. HIV-infected Ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012;54:1204–11.
    · extracted · source: references/10665-350214.sec-070.49.json
  51. Polyak CS, Yuhas K, Singa B, Khaemba M, Walson J, Richardson BA et al. Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-infected adults in Kenya: a randomized non-inferiority trial. PLoS Med. 2016;13:e1001934.
    · extracted · source: references/10665-350214.sec-070.50.json
  52. Wedderburn CJ, Penazzato M, Prendergast A, Slogrove A, Evans C. Co-trimoxazole prophylaxis for infants who are HIV-exposed and uninfected. PROSPERO 2021 CRD42021215059 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021215059, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.51.json
  53. Lockman S, Hughes M, Powis K, Ajibola G, Bennett K, Moyo S et al. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial. Lancet Global Health. 2017;5:e491–500.
    · extracted · source: references/10665-350214.sec-070.52.json
  54. Daniels B, Coutsoudis A, Moodley-Govender E, Mulol H, Spooner E, Kiepiela P et al. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial. Lancet Glob Health. 2019;7:e1717–27.
    · extracted · source: references/10665-350214.sec-070.53.json
  55. Powis KM, Souda S, Lockman S, Ajibola G, Bennett K, Leidner J et al. Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV-exposed infants in a randomized controlled trial, Botswana. J Int AIDS Soc. 2017;20:11.
    · extracted · source: references/10665-350214.sec-070.54.json
  56. D’Souza AW, Moodley-Govender E, Berla B, Kelkar T, Wang B, Sun X et al. Cotrimoxazole prophylaxis increases resistance gene prevalence and alpha-diversity but decreases beta-diversity in the gut microbiome of human immunodeficiency virus-exposed, uninfected infants. Clin Infect Dis. 2020;71:2858–68.
    · extracted · source: references/10665-350214.sec-070.55.json
  57. Sandison TG, Homsy J, Arinaitwe E, Wanzira H, Kakuru A, Bigira V et al. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ. 2011;342:d1617.
    · extracted · source: references/10665-350214.sec-070.56.json
  58. Homsy J, Dorsey G, Arinaitwe E, Wanzira H, Kakuru A, Bigira V et al. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial. Lancet Glob Health. 2014;2:e727–36.
    · extracted · source: references/10665-350214.sec-070.57.json
  59. Kamya MR, Kapisi J, Bigira V, Clark TD, Kinara S, Mwangwa F et al. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial. AIDS. 2014;28:2701–9.
    · extracted · source: references/10665-350214.sec-070.58.json
  60. Smith C, Wedderburn CJ, Penazzato M, Gibb D, Slogrove A, Evans C et al. Co-trimoxazole prophylaxis for children born to mothers with HIV: predicted impact of different strategies on mortality up to the age of two years. International Workshop on HIV Pediatrics 2021, 16–17 July 2021, virtual (https://academicmedicaleducation.com/meeting/international-workshop-hiv-pediatrics-2021/slide-set/co-trimoxazole-prophylaxis-children, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.59.json
  61. Improving early childhood development: WHO guideline. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/331306, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.60.json
  62. McHenry MS, McAteer CI, Oyungu E, McDonald BC, Bosma CB, Mpofu PB et al. Neurodevelopment in young children born to HIV-infected mothers: a meta-analysis. Pediatrics. 2018;141:e20172888.
    · extracted · source: references/10665-350214.sec-070.61.json
  63. Sherr L, Mueller J, Varrall R. A systematic review of cognitive development and child human immunodeficiency virus infection. Psychol Health Med. 2009;14:387–404.
    · extracted · source: references/10665-350214.sec-070.62.json
  64. WHO, UNICEF. Nurturing care framework for children affected by HIV: early childhood development and children affected by HIV. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/handle/10665/332904, accessed 27 September 2021).
    · extracted · link · source: references/10665-350214.sec-070.63.json